Lawrence P. Guiheen, Director at ADMA BIOLOGICS, INC. (ADMA), bought 25,000 shares at $4.00 ($100K) on 2019-05-17, disclosed to the SEC on 2019-05-21.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ADMA | SELL | 2024-09-11 | $166K | — | Filing → |
| ADMA | BUY | 2020-02-11 | $70K | — | Filing → |
| ADMA | BUY | 2018-06-11 | $96K | — | Filing → |